Robot-assisted surgery for lung and chest tumors
This study tests a new robot-assisted system to perform chest surgeries, such as removing lung tumors. It aims to see if the robot is safe and effective for people who need these procedures.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You need surgery to remove a lung tumor that is early-stage or has spread to the lung in a limited way, or to remove a tumor in the chest (mediastinum).
- Your overall health is stable enough for surgery (classified as ASA grade I–III by your doctor).
- You have not had chest surgery before and are not being treated for another cancer that would make this trial unsafe.
- You do not have severe bleeding problems, severe obesity (BMI 30 or higher), or serious heart, lung, liver, brain, or kidney disease.
- You do not need emergency surgery and are not dealing with alcohol or drug addiction.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a new surgical robot that uses only one small opening in the chest to remove a lung segment or lobe. It aims to see if the robot is safe and effective for patients who need this type of surgery.
This trial looks back at medical records to compare two types of breast-conserving surgery (robot-assisted vs. endoscopic) for women with early-stage breast cancer. It's for women who are good candidates for keeping their breast and who want a less invasive surgical option.
This study compares two types of minimally invasive lung surgery for early-stage lung cancer. One method uses a robotic arm, the other uses a small camera and long instruments through small cuts. The goal is to see which one gives better results for removing the cancer.
This trial tests whether combining immunotherapy with chemotherapy before robot-assisted lung surgery improves outcomes for patients with stage II–III non-small cell lung cancer. The goal is to shrink the tumor before surgery and then remove it completely using minimally invasive robotic techniques.
This study tests a new system called EAS1 for people with early-stage lung cancer who are already scheduled for surgery. The goal is to see if the device is safe and works well, and it may offer a less invasive way to remove small lung tumors.
This trial tests whether robotic-assisted surgery for lung cancer is safe and effective in elderly patients. It may be a good option if you are older and able to undergo surgery.
Hear when a new Thoracic Surgery trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.